F19.20
Other psychoactive substance dependence, uncomplicated
Clinical Classification Guidelines
Inclusion Terms
- Other (or unknown) substance use disorder, moderate
- Other (or unknown) substance use disorder, severe
Medical Intelligence & Overview
ICD-10 Code F19.20 describes a condition where an individual is dependent on psychoactive substances but without any complications such as additional health problems or mental health issues. This classification applies to those with a moderate or severe substance use disorder involving substances like opioids, stimulants, or other drugs that affect the mind and body. Recognizing and understanding this condition is essential for seeking appropriate care and support.
Causes & Symptoms
Clinical Causes: Repeated use of psychoactive substances leading to physical and psychological dependence. Genetic predispositions influencing how a person responds to certain substances. Environmental factors, such as stress, peer pressure, or exposure to environments where drug use is common. Mental health conditions that may increase vulnerability to substance dependence. History of trauma or adverse childhood experiences that can contribute to substance use behaviors.
Key Symptoms: Craving or a strong desire to use the substance. Difficulty controlling or reducing substance intake despite wanting to do so. Tolerance, requiring increased amounts of the substance to achieve the same effect. Withdrawal symptoms when not using the substance, such as sweating, nausea, or agitation. Neglect of responsibilities at work, school, or home due to substance use. Continued use despite awareness of physical, mental, or social problems related to the substance. Spending significant time obtaining, using, or recovering from the effects of the substance.
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a comprehensive assessment by healthcare professionals, typically including a detailed medical and psychological history, physical examination, and often standardized screening tools. The clinician evaluates patterns of substance use, the presence of withdrawal symptoms, tolerance levels, and the impact on daily functioning. Diagnosis adheres to established criteria for substance use disorders, considering severity and the extent of dependence.
Treatment Protocols: Treatment approaches for other psychoactive substance dependence aim to support recovery and reduce the risk of relapse. Common interventions include: - Detoxification: Medical supervision during withdrawal to manage symptoms safely. - Behavioral therapies: Counseling methods like cognitive-behavioral therapy to modify problematic thoughts and behaviors. - Medication-assisted treatment: Use of medications to reduce cravings or manage withdrawal symptoms. - Support groups: Participation in community-based programs or peer support communities. - Long-term follow-up: Ongoing care to sustain recovery and address any relapses or challenges. It's important for individuals to seek personalized treatment plans from healthcare professionals specializing in addiction medicine.
Clinical Advice & FAQs
Billing Guidance
Is F19.20 a billable ICD-10 code?
Yes, F19.20 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F19.20?
Clinical documentation must specify the nature of Other psychoactive substance dependence, uncomplicated and any associated comorbidities for accurate reporting.
Cite this Clinical Reference